The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade.
 
Stephen W. Reese
No Relationships to Disclose
 
Hui Jiang
No Relationships to Disclose
 
Fengshen Kuo
No Relationships to Disclose
 
Chih-Ying Wu
No Relationships to Disclose
 
Lynda Vuong
No Relationships to Disclose
 
Eduardo Mascareno
No Relationships to Disclose
 
Arnold Oparanozie
No Relationships to Disclose
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Aveo; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Merck; Pfizer
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Consulting or Advisory Role - Affimed Therapeutics; AVEO; Calithera Biosciences; Eisai; Exelixis; Genentech; Merck; MicuRx Pharmaceuticals; Oncorena; OnQuality Pharmaceuticals
Research Funding - Pfizer
Other Relationship - BMS
(OPTIONAL) Uncompensated Relationships - Aravive; BMS; Genentech/Roche
 
Eduard Reznik
No Relationships to Disclose
 
Victor E. Reuter
Consulting or Advisory Role - Cepheid
(OPTIONAL) Uncompensated Relationships - PAIGE.AI
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
(OPTIONAL) Uncompensated Relationships - AngioDynamics; Steba Biotech
 
Paul Russo
No Relationships to Disclose
 
Ying-Bei Chen
No Relationships to Disclose
 
Ritesh R Kotecha
Consulting or Advisory Role - Eisai; Eisai
Research Funding - Allogene Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
 
A. Ari Hakimi
Consulting or Advisory Role - Merck